New Drugs and Evolving Treatment Patterns in Lupus Nephritis: How Nephrologists and Rheumatologists Are Responding Differently to New Treatment Options

被引：0
|
作者：
Hurtado, Tucker B. [1 ]
Robinson, Jennifer [1 ]
Rex, Ryan [1 ]
机构：
[1] Spherix Global Insights, Spherix Adv Analyt Grp, Exton, PA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO1435
引用
收藏
页码：454 / 454
页数：1
相关论文
共 50 条
  • [1] New Treatment Options in Lupus Nephritis
    Pauline M. Montigny
    Frédéric A. Houssiau
    Archivum Immunologiae et Therapiae Experimentalis, 2022, 70
  • [2] New Treatment Options in Lupus Nephritis
    Montigny, Pauline M.
    Houssiau, Frederic A.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2022, 70 (01)
  • [3] Will New Treatment Options for Lupus Nephritis Be Affordable?
    Teng, Y. K. Onno
    Rabelink, Ton J. J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 340 - 341
  • [4] New Treatment Regimens, New Drugs, and New Treatment Goals for Lupus Nephritis
    Rossi, Giovanni M.
    Vaglio, Augusto
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [5] New prospects for treatment of lupus nephritis
    Balow, JE
    Boumpas, DT
    Austin, HA
    SEMINARS IN NEPHROLOGY, 2000, 20 (01) : 32 - 39
  • [6] A new old treatment for lupus nephritis
    Mok, Chi Chiu
    LANCET, 2021, 397 (10289): : 2027 - 2029
  • [7] Treatment of severe lupus nephritis: the new horizon
    Chan, Tak Mao
    NATURE REVIEWS NEPHROLOGY, 2015, 11 (01) : 46 - 61
  • [8] Treatment of severe lupus nephritis: the new horizon
    Tak Mao Chan
    Nature Reviews Nephrology, 2015, 11 : 46 - 61
  • [9] Lupus nephritis: new progress in diagnosis and treatment
    Yu, Chen
    Li, Ping
    Dang, Xin
    Zhang, Xuan
    Mao, Yonghui
    Chen, Xiangmei
    JOURNAL OF AUTOIMMUNITY, 2022, 132
  • [10] New treatment options for lupus - a focus on belimumab
    Chiche, Laurent
    Jourde, Noemie
    Thomas, Guillemette
    Bardin, Nathalie
    Bornet, Charleric
    Darque, Albert
    Mancini, Julien
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 33 - 43
12345